Cell Line Overexpressing Human Cd303 Antigen - EP3277723

The patent EP3277723 was granted to Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Jun 17, 2020. The application was originally filed on Mar 31, 2016 under application number EP16714843A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3277723

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP16714843A
Filing Date
Mar 31, 2016
Status
Granted And Under Opposition
May 15, 2020
Grant Date
Jun 17, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

POHLMANMar 17, 2021POHLMANWITHDRAWN

Patent Citations (1) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2014093396

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents